Although there is no histological evidence of carcinogenesis, the lack of immunoreactivity with monoclonal antibodies against the INI1 protein in the BB group, according to our findings, suggested an increase in susceptibility or an early sign of soft tissue sarcoma. The gene discussed is SMARCB1; the disease is soft tissue sarcoma.